In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sankyo Co. Ltd.

Division of Daiichi Sankyo Co. Ltd.
www.sankyo.co.jp/english

Latest From Sankyo Co. Ltd.

After A Dry 2013, Daiichi Sankyo Looks To Partners To Make It Rain

With only one deal in the last year, Daiichi Sankyo is ready for more deal-making with a new biz dev head and the acquisitions of oncology company Plexxikon and generics play Ranbaxy well behind it.

BioPharmaceutical Japan

After A Dry 2013, Daiichi Sankyo Looks To Partners To Make It Rain

With only one deal in the last year, Daiichi Sankyo is ready for more deal-making with a new biz dev head and the acquisitions of oncology company Plexxikon and generics play Ranbaxy well behind it.

BioPharmaceutical United States

Best of the Blog: Start-Up May 2008

In May, Windhover's editorial staff posted 35 articles to the blog, covering biopharma, device and diagnostics R&D, business development, regulatory and commercial news. Here are a few of our favorite SU oriented blog posts that didn't make it into stories covered elsewhere in this month's magazine: SR One 2.0?, BMS Gets KAI Heart Attack Compound Pumping, and Covidien Takes Small Bites.

Deals Update April 2007

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Medical Device
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register